These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 22338098)

  • 1. Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes.
    Sung KC; Jeong WS; Wild SH; Byrne CD
    Diabetes Care; 2012 Apr; 35(4):717-22. PubMed ID: 22338098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the fatty liver index as an indicator of hepatic steatosis for predicting incident diabetes independently of insulin resistance in a Korean population.
    Jung CH; Lee WJ; Hwang JY; Yu JH; Shin MS; Lee MJ; Jang JE; Leem J; Park JY; Kim HK
    Diabet Med; 2013 Apr; 30(4):428-35. PubMed ID: 23278318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance, inflammation and fatty liver.
    Sung KC; Lee MY; Kim YH; Huh JH; Kim JY; Wild SH; Byrne CD
    Atherosclerosis; 2018 Aug; 275():50-57. PubMed ID: 29860108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty Liver, Insulin Resistance, and Obesity: Relationships With Increase in Coronary Artery Calcium Over Time.
    Sung KC; Ryu S; Lee JY; Lee SH; Cheong ES; Wild SH; Byrne CD
    Clin Cardiol; 2016 Jun; 39(6):321-8. PubMed ID: 26997000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of fatty liver and risk of incident diabetes.
    Sung KC; Wild SH; Byrne CD
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3637-43. PubMed ID: 23873989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non alcoholic fatty liver disease and risk of incident diabetes in subjects who are not obese.
    Sung KC; Seo DC; Lee SJ; Lee MY; Wild SH; Byrne CD
    Nutr Metab Cardiovasc Dis; 2019 May; 29(5):489-495. PubMed ID: 30940491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of insulin resistance and cardiometabolic risk in Korean children and adolescents: a population-based study.
    Yi KH; Hwang JS; Kim EY; Lee SH; Kim DH; Lim JS
    Diabetes Res Clin Pract; 2014 Jan; 103(1):106-13. PubMed ID: 24290751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative contributions of insulin resistance and β-cell dysfunction to the development of Type 2 diabetes in Koreans.
    Kim CH; Kim HK; Kim EH; Bae SJ; Park JY
    Diabet Med; 2013 Sep; 30(9):1075-9. PubMed ID: 23600561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes.
    Sung KC; Kim SH
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1093-7. PubMed ID: 21252243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolically healthy obesity is associated with an increased risk of diabetes independently of nonalcoholic fatty liver disease.
    Chang Y; Jung HS; Yun KE; Cho J; Ahn J; Chung EC; Shin H; Ryu S
    Obesity (Silver Spring); 2016 Sep; 24(9):1996-2003. PubMed ID: 27474900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent impact of body mass index and metabolic syndrome on the risk of type 2 diabetes in Koreans.
    Kim CH; Kim HK; Bae SJ; Kim EH; Park JY
    Metab Syndr Relat Disord; 2012 Oct; 10(5):321-5. PubMed ID: 22621338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-sensitive adiposity is associated with a relatively lower risk of diabetes than insulin-resistant adiposity: the Bogalusa Heart Study.
    Zhang T; Li Y; Zhang H; Sun D; Li S; Fernandez C; Harville E; Bazzano L; He J; Chen W
    Endocrine; 2016 Oct; 54(1):93-100. PubMed ID: 27060004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overweight, obesity and the risk of LADA: results from a Swedish case-control study and the Norwegian HUNT Study.
    Hjort R; Ahlqvist E; Carlsson PO; Grill V; Groop L; Martinell M; Rasouli B; Rosengren A; Tuomi T; Åsvold BO; Carlsson S
    Diabetologia; 2018 Jun; 61(6):1333-1343. PubMed ID: 29589073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic consequences of hepatic steatosis in overweight and obese adolescents.
    Wicklow BA; Wittmeier KD; MacIntosh AC; Sellers EA; Ryner L; Serrai H; Dean HJ; McGavock JM
    Diabetes Care; 2012 Apr; 35(4):905-10. PubMed ID: 22357180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of type 2 diabetes mellitus according to the categories of body mass index: the Korean Genome and Epidemiology Study (KoGES).
    Jung JY; Park SK; Oh CM; Ryoo JH; Choi JM; Choi YJ
    Acta Diabetol; 2018 May; 55(5):479-484. PubMed ID: 29455425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children.
    El-Koofy NM; Anwar GM; El-Raziky MS; El-Hennawy AM; El-Mougy FM; El-Karaksy HM; Hassanin FM; Helmy HM
    Saudi J Gastroenterol; 2012; 18(1):44-9. PubMed ID: 22249092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body fat distribution and insulin resistance: beyond obesity in nonalcoholic fatty liver disease among overweight men.
    Park SH; Kim BI; Kim SH; Kim HJ; Park DI; Cho YK; Sung IK; Sohn CI; Kim H; Keum DK; Kim HD; Park JH; Kang JH; Jeon WK
    J Am Coll Nutr; 2007 Aug; 26(4):321-6. PubMed ID: 17906183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin resistance and metabolic syndrome in nonobese Indian patients with non-alcoholic fatty liver disease.
    Bhat G; Baba CS; Pandey A; Kumari N; Choudhuri G
    Trop Gastroenterol; 2013; 34(1):18-24. PubMed ID: 23923370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTproBNP in insulin-resistance mediated conditions: overweight/obesity, metabolic syndrome and diabetes. The population-based Casale Monferrato Study.
    Baldassarre S; Fragapani S; Panero A; Fedele D; Pinach S; Lucchiari M; Vitale AR; Mengozzi G; Gruden G; Bruno G
    Cardiovasc Diabetol; 2017 Sep; 16(1):119. PubMed ID: 28946871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of risk factors on insulin resistance in patients with overweight and obesity.
    Maksymets T; Karpyshyn N; Gutor T; Sklyarova H; Sklyarov E
    Wiad Lek; 2018; 71(3 pt 1):558-560. PubMed ID: 29783224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.